Shareholders Equity and Capital Stock (Details 7) |
9 Months Ended |
|---|---|
|
Sep. 30, 2021
USD ($)
$ / shares
shares
| |
| Aggregate Intrinsic Value | $ 11,630,945,000 |
| Exercise price $0.75 | |
| Exercise price | $ / shares | $ 0.75 |
| Number of warrants | shares | 8,038,000 |
| Remaining contractual life (years) | 9 months 18 days |
| Aggregate Intrinsic Value | $ 3,898,430,000 |
| Expiry | Aug. 04, 2022 |
| Exercise price $1.35 | |
| Exercise price | $ / shares | $ 1.35 |
| Number of warrants | shares | 16,880,530 |
| Remaining contractual life (years) | 2 years 3 months 18 days |
| Aggregate Intrinsic Value | $ 3,122,898 |
| Expiry | Feb. 04, 2024 |
| Warrants | |
| Exercise price | $ / shares | $ 1.16 |
| Number of warrants | shares | 24,918,530 |
| Remaining contractual life (years) | 1 year 10 months 24 days |
| Aggregate Intrinsic Value | $ 7,021,328,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|